Literature DB >> 19647352

Synthesis of some new 1,2,4-triazoles starting from isonicotinic acid hydrazide and evaluation of their antimicrobial activities.

Hacer Bayrak1, Ahmet Demirbas, Neslihan Demirbas, Sengül Alpay Karaoglu.   

Abstract

5-Pyridin-4-yl-1,3,4-oxadiazole-2-thiol (2) was obtained from the reaction of isonicotinic acid hydrazide with carbon disulfide in basic media and converted into 4-amino-5-pyridin-4-yl-4H-1,2,4-triazole-3-thiol (5) by the treatment with hydrazine hydrate. The synthesis of 3 and 6 was performed from the reaction of 2 and 5 with ethyl bromide. The treatment of 5 with 4-fluorobenzaldehyde or indol-3-carbaldehyde resulted in the formation of 4-[(arylmethylene)amino]-5-pyridin-4-yl-4H-1,2,4-triazole-3-thiols (7a and 7b). The reactions of 2, 5 and 7a with some primary and secondary amines in the presence of formaldehyde afforded the corresponding Mannich bases, 4a, 4b, 9a-9c and 8. All newly synthesized compounds were screened for their antimicrobial activity. The antimicrobial activity study revealed that all the compounds screened showed good or moderate activity except compounds 2, 7a, 7b, 8 and 9b.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647352     DOI: 10.1016/j.ejmech.2009.05.022

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  20 in total

1.  Novel triazole alcohol antifungals derived from fluconazole: design, synthesis, and biological activity.

Authors:  Seyedeh Mahdieh Hashemi; Hamid Badali; Mohammad Ali Faramarzi; Nasrin Samadi; Mohammad Hosein Afsarian; Hamid Irannejad; Saeed Emami
Journal:  Mol Divers       Date:  2014-09-03       Impact factor: 2.943

2.  2-Chloro-N'-(2-chloro-benzyl-idene)benzohydrazide.

Authors:  Dong-Hui Zou; Hong Guan; Xiao-Hua Zhang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-28

3.  Studies on Absorption and Emission Characteristics of Inclusion Complexes of Some 4-Arylidenamino-5-phenyl-4H-1, 2, 4-triazole-3-thiols.

Authors:  Sunakar Panda; Sashikanta Nayak
Journal:  J Fluoresc       Date:  2015-11-21       Impact factor: 2.217

Review 4.  Mannich bases in medicinal chemistry and drug design.

Authors:  Gheorghe Roman
Journal:  Eur J Med Chem       Date:  2014-10-30       Impact factor: 6.514

5.  Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid.

Authors:  Sana Yaqoob; Nourina Nasim; Rahila Khanam; Yan Wang; Almas Jabeen; Urooj Qureshi; Zaheer Ul-Haq; Hesham R El-Seedi; Zi-Hua Jiang; Farooq-Ahmad Khan
Journal:  Molecules       Date:  2021-02-26       Impact factor: 4.411

6.  Antimicrobial and antiurease activities of newly synthesized morpholine derivatives containing an azole nucleus.

Authors:  Hakan Bektaş; Sule Ceylan; Neslihan Demirbaş; Sengül Alpay-Karaoğlu; Bahar Bilgin Sökmen
Journal:  Med Chem Res       Date:  2012-11-29       Impact factor: 1.965

7.  Microbiologically active Mannich bases derived from 1,2,4-triazoles. The effect of C-5 substituent on antibacterial activity.

Authors:  Tomasz Plech; Monika Wujec; Magdalena Majewska; Urszula Kosikowska; Anna Malm
Journal:  Med Chem Res       Date:  2012-09-29       Impact factor: 1.965

8.  Discovery of ( ±)-3-(1H-pyrazol-1-yl)-6,7-dihydro-5H-[1,2,4]triazolo[3,4-b][1,3,4] thiadiazine derivatives with promising in vitro anticoronavirus and antitumoral activity.

Authors:  Parameshwara Chary Jilloju; Leentje Persoons; Sathish Kumar Kurapati; Dominique Schols; Steven De Jonghe; Dirk Daelemans; Rajeswar Rao Vedula
Journal:  Mol Divers       Date:  2021-06-24       Impact factor: 2.943

9.  (E)-4-Meth-oxy-N'-[(pyridin-4-yl)methyl-idene]benzohydrazide monohydrate.

Authors:  Muhammad Taha; Humera Naz; Aqilah Abd Rahman; Nor Hadiani Ismail; Yousuf Sammer
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-08-25

10.  (E)-N'-(3,4-Dimeth-oxy-benzyl-idene)-4-meth-oxy-benzohydrazide.

Authors:  Muhammad Taha; Humera Naz; Aqilah Abd Rahman; Nor Hadiani Ismail; Yousuf Sammer
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.